Risedronate Sodium in Post Menopausal Osteoporosis

Update Il y a 4 ans
Reference: NCT00453492

Woman Man

  • | Country :
  • Turkey
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective is to compare subject satisfaction of once a week dosing of 35 mg Actonel to once daily dosing of 5 mg Actonel in postmenopausal osteoporotic women. The secondary objectives are to measure compliance (50 % drug taken), and persistence, [and urinary NTx (N-telopeptides) (optional)].


Inclusion criteria

  • Osteoporosis Postmenopausal

Links